235 related articles for article (PubMed ID: 25608160)
41. 18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT.
Samarin A; Hüllner M; Queiroz MA; Stolzmann P; Burger IA; von Schulthess G; Veit-Haibach P
Nucl Med Commun; 2015 Dec; 36(12):1165-73. PubMed ID: 26397999
[TBL] [Abstract][Full Text] [Related]
42. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
Nuñez R; Macapinlac HA; Yeung HW; Akhurst T; Cai S; Osman I; Gonen M; Riedel E; Scher HI; Larson SM
J Nucl Med; 2002 Jan; 43(1):46-55. PubMed ID: 11801702
[TBL] [Abstract][Full Text] [Related]
43. 18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer.
Mertens LS; Mir MC; Scott AM; Lee ST; Fioole-Bruining A; Vegt E; Vogel WV; Manecksha R; Bolton D; Davis ID; Horenblas S; van Rhijn BW; Lawrentschuk N
Urology; 2014 Feb; 83(2):393-8. PubMed ID: 24468513
[TBL] [Abstract][Full Text] [Related]
44. Utility of computed tomography and
Kaneko M; Kawai K; Nozawa H; Hata K; Tanaka T; Nishikawa T; Shuno Y; Sasaki K; Emoto S; Murono K; Ishii H; Sonoda H; Watadani T; Takao H; Abe O; Ishihara S
Colorectal Dis; 2020 Dec; 22(12):1984-1990. PubMed ID: 32780478
[TBL] [Abstract][Full Text] [Related]
45. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
46. 18F-FDG PET/CT in a case of malignant priapism secondary to metastasis from mucoid adenocarcinoma of the cecum.
Sasikumar A; Harisankar CN; Bhattacharya A; Kapoor R; Mittal BR
Clin Nucl Med; 2013 Feb; 38(2):e91-2. PubMed ID: 23334147
[TBL] [Abstract][Full Text] [Related]
47. Proposal of a new acquisition protocol for bladder cancer visualization with 18F-FDG PET/CT.
Chondrogiannis S; Marzola MC; Colletti PM; Rubello D
Clin Nucl Med; 2015 Jan; 40(1):e78-80. PubMed ID: 24566416
[TBL] [Abstract][Full Text] [Related]
48. Isolated Calcaneal Metastasis: An Unusual Presentation of Lung Carcinoma as Heel Pain.
Singh C; Gupta M; Singh J; Ali A
Clin Nucl Med; 2016 Mar; 41(3):214-6. PubMed ID: 26562577
[TBL] [Abstract][Full Text] [Related]
49. Urachal carcinoma: CT findings.
Brick SH; Friedman AC; Pollack HM; Fishman EK; Radecki PD; Siegelbaum MH; Mitchell DG; Lev-Toaff AS; Caroline DF
Radiology; 1988 Nov; 169(2):377-81. PubMed ID: 2845472
[TBL] [Abstract][Full Text] [Related]
50. Primary Pulmonary Mucinous Adenocarcinoma Was Better Visualized on Delayed FDG PET/CT Imaging.
Zheng N; Bai X; Niu R; Wang X
Clin Nucl Med; 2016 Oct; 41(10):809-11. PubMed ID: 27454595
[TBL] [Abstract][Full Text] [Related]
51. Asymptomatic metastasis to the larynx detected by FDG PET/CT in a patient with recurrent rectal adenocarcinoma.
Chen TY; Hung GU; Hung CC; Chiu JS; Kao CH
Clin Nucl Med; 2012 Jul; 37(7):e178-80. PubMed ID: 22691530
[TBL] [Abstract][Full Text] [Related]
52. [Bronchioloalveolar carcinoma as potencial cause of false negative with PET-FDG].
Reyes Ojeda MD; López Aznar DJ; Abreu Sánchez P; Uruburu Garcia E; Martínez Carsi C; Sopena Monforte R
Rev Esp Med Nucl; 2005; 24(4):254. PubMed ID: 16122411
[No Abstract] [Full Text] [Related]
53. Whole Body MRI in the Staging of Esophageal Cancer--A Prospective Comparison with Whole Body 18F-FDG PET-CT.
Malik V; Harmon M; Johnston C; Fagan AJ; Claxton Z; Ravi N; O'Toole D; Muldoon C; Keogan M; Reynolds JV; Meaney JF
Dig Surg; 2015; 32(5):397-408. PubMed ID: 26315570
[TBL] [Abstract][Full Text] [Related]
54. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
55. A Rare Case of Primary Endometrial Hepatoid Adenocarcinoma on 18F-FDG PET/CT.
Yin H; Hu Y; Xiu Y; Luo R; Shi H
Clin Nucl Med; 2019 Jul; 44(7):e425-e427. PubMed ID: 30985410
[TBL] [Abstract][Full Text] [Related]
56. Delayed imaging of the pelvis with diluted and filled bladder: a simple and efficient method in FDG PET/CT imaging of bladder carcinoma.
Halac M; Aliyev A; Yılmaz S; Ozhan M; Kaya R; Sağer S; Ergül N
Clin Nucl Med; 2012 Aug; 37(8):778-80. PubMed ID: 22785509
[TBL] [Abstract][Full Text] [Related]
57. FDG-PET/CT of Vulvar Adenocarcinoma With Diffuse Metastases.
Patel D; Anderson TM; Lu Y
Clin Nucl Med; 2016 Sep; 41(9):710-1. PubMed ID: 27187733
[TBL] [Abstract][Full Text] [Related]
58. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
59. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
60. Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy.
Rouanne M; Girma A; Neuzillet Y; Vilain D; Radulescu C; Letang N; Yonneau L; Hervé JM; Botto H; Le Stanc E; Lebret T
Eur J Surg Oncol; 2014 Dec; 40(12):1724-30. PubMed ID: 25242381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
